Role of C-type Lectin Receptor to C.albicans on Promotion of Inflamantory Diseases

Erna Sulistyani

Authors

Erna Sulistyani Ilmu Penyakit Mulut, Fakultas Kedokteran Gigi Universitas Jember

Keywords:

C. albicans, CLR, Cytokine, Inflamatory Disease

Abstract

In early 2010 there was a very rapid progress in the development of immunity to fungi, i.e the discovery of CLR. CLR is one of the PRR receptors found in immune cells that recognize the cell wall of fungi and then trigger a transduction signal that eventually provoke the production of various proinflamatory include IL1β, IL6, TNF α and induce polarization Th17. In the condition of infection the number of innate immune cells increases dramatically, lead to increasing of cytokines produced. Both cytokines and the cells that produce them enter the bloodstream. If there is unbalance level of pro and anti inflammatory cytokine, various inflammatory and/or autoimmune diseases can be occur. Unlike the focal concept infection, where the agent will cause disease if enters the blood vessels, through this concept a fungal infection at epithelium can lead to inflammatory diseases in other part of body without having to go through fungus

Downloads

Download data is not yet available.

References

Romani L. Immunity to fungal infections. Nature Reviews Immunology. 2011;11:288-275. doi:10.1038/nri2939.

Mark D.Turner, BelindaNedjai, TaraHurst, Daniel J.Pennington, Cytokines and chemokines: At the crossroads of cell signalling and inflammatory diseaseBiochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2014;1843(11): 2582-2563.

Jenkinson H F, Douglas J L. Interactions between Candida Species and Bacteria in Mixed Infections In Polymicrobial Diseases. In Editor Brogden KA, Editor Guthmiller JM, editors. Washington DC:ASM Press;2002.

Yapar N. Epidemiology and Risk Factors for invasive Candidiasis. Therapeutics and Clinical Risk Management.2014;10: 105-95.

Gupta S, Wilson BB.Mucosal Candidiasis. Medscape.Updated: Aug 28, 2017 [Cited September132017]. Available fromhttp://emedicine.medscape.com/article/1075227-overview

Gow N A, van de Veerdonk, F L, Brown A J, Netea M G. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nature Reviews Microbiology; 2012, 10(2):122-112.

Chaffin W L, López-Ribot, J L, Casanova M, Gozalbo D, Martínez, J.Cell Wall and Secreted Proteins of Candida albicans: Identification, Function, and Expression. Microbiology and Molecular Biology Reviews. 1998; 62(1):180-130.

Sheth C C, Hall R, Lewis L, Brown A J, Odds F C, Erwig L P, Gow NA.Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling. Medical Mycology. 2011;49 (5):524-513.

Grubb S E W, Murdoch C, Sudbery P E, Saville S P, Lopez-Ribot J L, Thornhill M H. Candida albicans-Endothelial Cell Interactions: a Key Step in the Pathogenesis of Systemic Candidiasis. Infection and Immunity. 2008; 76(10): 4377–4370.

Levitz S. Innate Recognition of Fungal Cell Walls. PLoS Pathog.2010 ; 6(4):3-1.

Kerscher B, Willment J A, Brown G D. The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol. 2013; 25 (5): 277-271.

Tang J, Lin G, Langdon W Y, Tao L, Zhang J. Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity. Frontiers in Immunology.2018; 9:123. http://doi.org/10.3389/fimmu.2018.00123.

Ifrim D C, Joosten L A, Kullberg B J, Jacobs L. Candida albicans Primes TLR Cytokine Responses through a Dectin-1/Raf-1–Mediated Pathway. J Immunol. 2013;190(8):4135–4129.

Piotr Wojdasiewicz, Łukasz A. Poniatowski, Dariusz Szukiewicz. The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis. Mediators of Inflammation. 2014; Article ID 561459, 19 pages, https://doi.org/10.1155/2014/561459.

Borthwick, L A.The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Seminars in Immunopathology,2016; 38(4): 534–517. http://doi.org/10.1007/s00281-016-0559-z

Yamada H. Current perspectives on the role of IL-17 in autoimmune disease. Journal of Inflammation Research. 2010; 3:44-33.